Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948888508> ?p ?o ?g. }
- W2948888508 endingPage "727" @default.
- W2948888508 startingPage "717" @default.
- W2948888508 abstract "BackgroundThe duration of protection offered by rotavirus vaccines varies across the world, and this variation is important to understanding and predicting the effects of the vaccines. There is now a large body of evidence on the efficacy of live oral rotavirus vaccines in different settings, but these data have never been synthesised to obtain robust estimates of efficacy by duration of follow-up. Our aim is to estimate the efficacy of live oral rotavirus vaccines at each point during follow-up and by mortality stratum.MethodsIn our meta-regression study, we identified all randomised controlled trials of rotavirus vaccines published until April 4, 2018, using the results of a Cochrane systematic review, and cross checked these studies against those identified by another systematic review. We excluded trials that were based on special populations, trials without an infant schedule, and trials without clear reporting of numbers of enrolled infants and events in different periods of follow-up. For all reported periods of follow-up, we extracted the mean duration of follow-up (time since administration of the final dose of rotavirus vaccination), the number of enrolled infants, and case counts for rotavirus-positive severe gastroenteritis in both non-vaccinated and vaccinated groups. We used a Bayesian hierarchical Poisson meta-regression model to estimate the pooled cumulative vaccine efficacy (VE) and its waning with time for three mortality strata. We then converted these VE estimates into instantaneous VE (iVE).FindingsIn settings with low mortality (15 observations), iVE pooled for infant schedules of Rotarix and RotaTeq was 98% (95% credibility interval 93–100) 2 weeks following the final dose of vaccination and 94% (87–98) after 12 months. In medium-mortality settings (11 observations), equivalent estimates were 82% (74–92) after 2 weeks and 77% (67–84) after 12 months. In settings with high mortality (24 observations), there were five different vaccines with observation points for infant schedules. The pooled iVE was 66% (48–81) after 2 weeks of follow-up and 44% (27–59) after 12 months.InterpretationRotavirus vaccine efficacy is lower and wanes more rapidly in high-mortality settings than in low-mortality settings, but the earlier peak age of disease in high-mortality settings means that live oral rotavirus vaccines are still likely to provide substantial benefit.FundingBill & Melinda Gates Foundation." @default.
- W2948888508 created "2019-06-14" @default.
- W2948888508 creator A5007425462 @default.
- W2948888508 creator A5033151792 @default.
- W2948888508 creator A5037935415 @default.
- W2948888508 creator A5050444974 @default.
- W2948888508 creator A5051314999 @default.
- W2948888508 creator A5054966986 @default.
- W2948888508 creator A5061848201 @default.
- W2948888508 creator A5067911817 @default.
- W2948888508 date "2019-07-01" @default.
- W2948888508 modified "2023-10-18" @default.
- W2948888508 title "Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials" @default.
- W2948888508 cites W1965526538 @default.
- W2948888508 cites W1966417805 @default.
- W2948888508 cites W1982900907 @default.
- W2948888508 cites W1988557503 @default.
- W2948888508 cites W2002038622 @default.
- W2948888508 cites W2005036898 @default.
- W2948888508 cites W2009068239 @default.
- W2948888508 cites W2017226367 @default.
- W2948888508 cites W2017882908 @default.
- W2948888508 cites W2026800191 @default.
- W2948888508 cites W2039403264 @default.
- W2948888508 cites W2040079691 @default.
- W2948888508 cites W2040393189 @default.
- W2948888508 cites W2048170453 @default.
- W2948888508 cites W2051514059 @default.
- W2948888508 cites W2054554539 @default.
- W2948888508 cites W2057022620 @default.
- W2948888508 cites W2071848254 @default.
- W2948888508 cites W2075041765 @default.
- W2948888508 cites W2091969782 @default.
- W2948888508 cites W2093570108 @default.
- W2948888508 cites W2095204653 @default.
- W2948888508 cites W2101380815 @default.
- W2948888508 cites W2103861589 @default.
- W2948888508 cites W2106595147 @default.
- W2948888508 cites W2122916891 @default.
- W2948888508 cites W2127516971 @default.
- W2948888508 cites W2128322670 @default.
- W2948888508 cites W2131073529 @default.
- W2948888508 cites W2135985984 @default.
- W2948888508 cites W2143233237 @default.
- W2948888508 cites W2146147908 @default.
- W2948888508 cites W2151100928 @default.
- W2948888508 cites W2163306701 @default.
- W2948888508 cites W2165384760 @default.
- W2948888508 cites W2168275109 @default.
- W2948888508 cites W2169605506 @default.
- W2948888508 cites W2170749337 @default.
- W2948888508 cites W2172173820 @default.
- W2948888508 cites W2281017812 @default.
- W2948888508 cites W2315960053 @default.
- W2948888508 cites W2328134362 @default.
- W2948888508 cites W2346899796 @default.
- W2948888508 cites W2402321912 @default.
- W2948888508 cites W2409894378 @default.
- W2948888508 cites W2563450837 @default.
- W2948888508 cites W2601776853 @default.
- W2948888508 cites W2602314417 @default.
- W2948888508 cites W2604343089 @default.
- W2948888508 cites W2606589148 @default.
- W2948888508 cites W2620681788 @default.
- W2948888508 cites W2754303501 @default.
- W2948888508 cites W2760380650 @default.
- W2948888508 cites W2770589232 @default.
- W2948888508 cites W2790804229 @default.
- W2948888508 cites W2791955517 @default.
- W2948888508 cites W2793865752 @default.
- W2948888508 cites W2798152895 @default.
- W2948888508 cites W2912128032 @default.
- W2948888508 cites W4231603137 @default.
- W2948888508 cites W4236114911 @default.
- W2948888508 cites W4241094133 @default.
- W2948888508 cites W4362206875 @default.
- W2948888508 doi "https://doi.org/10.1016/s1473-3099(19)30126-4" @default.
- W2948888508 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6595176" @default.
- W2948888508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31178289" @default.
- W2948888508 hasPublicationYear "2019" @default.
- W2948888508 type Work @default.
- W2948888508 sameAs 2948888508 @default.
- W2948888508 citedByCount "73" @default.
- W2948888508 countsByYear W29488885082019 @default.
- W2948888508 countsByYear W29488885082020 @default.
- W2948888508 countsByYear W29488885082021 @default.
- W2948888508 countsByYear W29488885082022 @default.
- W2948888508 countsByYear W29488885082023 @default.
- W2948888508 crossrefType "journal-article" @default.
- W2948888508 hasAuthorship W2948888508A5007425462 @default.
- W2948888508 hasAuthorship W2948888508A5033151792 @default.
- W2948888508 hasAuthorship W2948888508A5037935415 @default.
- W2948888508 hasAuthorship W2948888508A5050444974 @default.
- W2948888508 hasAuthorship W2948888508A5051314999 @default.
- W2948888508 hasAuthorship W2948888508A5054966986 @default.
- W2948888508 hasAuthorship W2948888508A5061848201 @default.
- W2948888508 hasAuthorship W2948888508A5067911817 @default.
- W2948888508 hasBestOaLocation W29488885081 @default.